Literature DB >> 11187121

Bone marrow transplantation without myeloablation for sickle cell disease.

L Krishnamurti, B R Blazar, J E Wagner.   

Abstract

Mesh：

Year:  2001        PMID： 11187121     DOI： 10.1056/NEJM200101043440119

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  Sickle cell diseases: current therapeutic options and potential pitfalls in preventive therapy for transcranial Doppler abnormalities.

Authors:  Sharada A Sarnaik
Journal:  Pediatr Radiol       Date:  2005-02-10

2.  Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization.

Authors:  Hong Xu; Jun Yan; Yiming Huang; Paula M Chilton; Chuanlin Ding; Carrie L Schanie; Li Wang; Suzanne T Ildstad
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

3.  A novel human gamma-globin gene vector for genetic correction of sickle cell anemia in a humanized sickle mouse model: critical determinants for successful correction.

Authors:  Ajay Perumbeti; Tomoyasu Higashimoto; Fabrizia Urbinati; Robert Franco; Herbert J Meiselman; David Witte; Punam Malik
Journal:  Blood       Date:  2009-05-27       Impact factor: 22.113

4.  Preliminary in vitro antisickilng properties of crude juice extracts of Persia Americana, Citrus sinensis, Carica papaya and Ciklavit®.

Authors:  E E J Iweala; F O Uhegbu; G N Ogu
Journal:  Afr J Tradit Complement Altern Med       Date:  2009-12-30

Review 5.  Umbilical cord blood: an evolving stem cell source for sickle cell disease transplants.

Authors:  Shalini Shenoy
Journal:  Stem Cells Transl Med       Date:  2013-04-11       Impact factor: 6.940

6.  Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics.

Authors:  Mitchell E Horwitz; Ivan Spasojevic; Ashley Morris; Marilyn Telen; James Essell; Cristina Gasparetto; Keith Sullivan; Gwynn Long; John Chute; Nelson Chao; David Rizzieri
Journal:  Biol Blood Marrow Transplant       Date:  2007-12       Impact factor: 5.742

7.  Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions.

Authors:  Shalini Shenoy
Journal:  Ther Adv Hematol       Date:  2013-10

8.  Unrelated donor allogeneic hematopoietic stem cell transplantation for patients with hemoglobinopathies using a reduced-intensity conditioning regimen and third-party mesenchymal stromal cells.

Authors:  Sandhya Kharbanda; Angela R Smith; Stephanie K Hutchinson; David H McKenna; James B Ball; Lawrence S Lamb; Rajni Agarwal; Kenneth I Weinberg; John E Wagner
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-24       Impact factor: 5.742

Review 9.  Cellular Therapies for the Treatment of Hematological Malignancies; Swine Are an Ideal Preclinical Model.

Authors:  Raimon Duran-Struuck; Christene A Huang; Abraham J Matar
Journal:  Front Oncol       Date:  2019-06-21       Impact factor: 6.244
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.